GLP-1 glucagon-like peptide 1
Selected indexed studies
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. (J Med Chem, 2015) [PMID:26308095]
- Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists. (Front Endocrinol (Lausanne), 2024) [PMID:39114288]
- Glucagon-like peptide-1 (GLP-1) signalling in the brain: From neural circuits and metabolism to therapeutics. (Br J Pharmacol, 2022) [PMID:34519026]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists. (2024) pubmed
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects. (2021) pubmed
- Boosting GLP-1 by Natural Products. (2021) pubmed
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. (2015) pubmed
- Glucagon-like peptide-1 (GLP-1) signalling in the brain: From neural circuits and metabolism to therapeutics. (2022) pubmed
- IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target. (2024) pubmed
- The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders: a systematic review and meta-analysis. (2025) pubmed
- Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. (2023) pubmed
- Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration. (2024) pubmed
- Glucagon-Like Peptide 1 (GLP-1) Action on Hypothalamic Feeding Circuits. (2025) pubmed